EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI

Rihito Aizawa, Takashi Ogata, Takayuki Goto, Tomoaki Otani, Kiyonao Nakamura, Yuki Kita, Ryusuke Nakamoto, Yoichi Shimizu, Takayuki Sumiyoshi, Kaoru Murakami, Kei Mizuno, Takashi Kobayashi und 2 weitere

Anticancer Research · 2025-06 · 45 (6) · 2515-2525

DOI: 10.21873/anticanres.17623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 27.05.2025. Verfasst von Rihito Aizawa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Whole Body Imaging, Magnetic Resonance Imaging. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsWhole Body ImagingMagnetic Resonance ImagingProstatic Neoplasms, Castration-ResistantHumansMaleAgedRetrospective StudiesAged, 80 and overMiddle AgedNeoplasm MetastasisGlutamate Carboxypeptidase IITreatment OutcomeAntigens, SurfaceRadiosurgery

Stichwörter der Autor:innen

PSMA-PET/CTProstate cancermetastasis-directed therapyoligo-metastasiswhole-body diffusion-weighted MRI

Substanzen

Glutamate Carboxypeptidase IIFOLH1 protein, humanAntigens, Surface

Autor:innen und Institutionen

  • Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University, Kyoto, Japan.
  • Department of Radiation Oncology, Kyoto City Hospital, Kyoto, Japan.
  • Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan; mizo@kuhp.kyoto-u.ac.jp.

Zitieren

APA

Aizawa, R., Ogata, T., Goto, T., Otani, T., Nakamura, K., Kita, Y., Nakamoto, R., Shimizu, Y., Sumiyoshi, T., Murakami, K., Mizuno, K., Kobayashi, T., Nakamoto, Y., & Mizowaki, T. (2025). Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI. Anticancer Research, 45(6), 2515-2525. https://doi.org/10.21873/anticanres.17623

Vancouver

Aizawa R, Ogata T, Goto T, Otani T, Nakamura K, Kita Y, et al. Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI. Anticancer Research. 2025;45(6):2515-2525. doi:10.21873/anticanres.17623

BibTeX
@article{Aizawa2025,
  author = {Aizawa, Rihito and Ogata, Takashi and Goto, Takayuki and Otani, Tomoaki and Nakamura, Kiyonao and Kita, Yuki and Nakamoto, Ryusuke and Shimizu, Yoichi and Sumiyoshi, Takayuki and Murakami, Kaoru and Mizuno, Kei and Kobayashi, Takashi and Nakamoto, Yuji and Mizowaki, Takashi},
  title = {Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI},
  journal = {Anticancer Research},
  year = {2025},
  volume = {45},
  number = {6},
  pages = {2515--2525},
  doi = {10.21873/anticanres.17623}
}
Kostenlos starten →